Quadruple prenatal screening by most advance
AutoDELFIA immunoassay system is reliable and high-quality results.
Quadruple Maternal Screening test is a
second trimester screening test for pregnant women for pregnant women as this
test to classify a patient as either high-risk or low-risk for chromosomal
abnormalities (Down Syndrome-Trisomy 21, Edward’s Syndrome-Trisomy 18) and
neural tube defects. It identifies the risk of the baby being affected.
This test is done between 14 and 22 weeks
of pregnancy. However, the best time for this test is between 15 and 20 weeks
of pregnancy.
Every pregnant woman is advised to take
this test, for detecting any abnormality in the fetus before birth.
Tests Parameter to check for:
This test measures the levels of four
marker AFP, Unconjugated Estriol, β
-HCG and inhibin A in blood, so known as the Quad Marker test.
Sample Collection Instruction:
Fasting not mandatory.
3 ml. (2 ml. Minimum) Serum from 1 SST (Gel
barrier tube).
Reported on
4th Working Day by 7:00 p.m.
The lab technician will collect blood
sample from the patient. This will be processed in a lab and the report
provided usually fourth day via SMS and Email.
To know more please Call 9801831090, 9801036380(WhatsApp)
Test Preparation for combined risk
assessment